Tag: #Global Trends

Key Development UK-based biopharmaceutical firm Mereo BioPharma and Sentynl Therapeutics (a rare disease commercial subsidiary of Indian pharmaceutical group Zydus... Read more

Key Development In a televised appearance on CNBC on August 11, 2026, Acting U.S. FDA Commissioner Kyle Diamantas reassured the... Read more

Key Development South Korean biopharmaceutical major Samsung Bioepis Co., Ltd. officially announced the commercial availability of the pre-filled syringe (PFS)... Read more

Key Development Biopharmaceutical major Bristol Myers Squibb (NYSE: BMY) has officially selected Generation Park in Houston, Texas, as the site... Read more

Key Development American biopharmaceutical leader Bristol Myers Squibb (NYSE: BMY) has officially announced a $2.3 billion investment to construct a... Read more

Key Development Biopharmaceutical major Innovent Biologics, Inc. (HKEX: 1801) and Japanese pharmaceutical company Daiichi Sankyo Company, Limited (TSE: 4568) have... Read more

Key Development Swedish rare disease specialist Swedish Orphan Biovitrum (Sobi) has executed an exclusive global licensing agreement valued at up... Read more

Key Development Danish biopharmaceutical major Novo Nordisk (OMX: NOVOb) and Amazon Web Services (AWS)—the cloud computing division of Amazon.com—have formally... Read more

Key Development Leading U.S. produce processor Taylor Farms (headquartered in Salinas, California) has officially initiated a voluntary recall covering multiple... Read more